References

Bennett C, Adams J, Knox K, et al. Clinical trials: Are they a good buy? J Clin Oncol. 2001;19:4330-4339.

Coalition of Cancer Cooperative Groups. Most cancer patients satisfied with clinical trial experience, yet, few aware of opportunity: study shows improved physician-patient communications could increase enrollment in cancer clinical trials [press release]. June 5, 2006. Accessed at www.cancertrialshelp.org/CTHpdf/CancerPatientsSatisfied5June06.pdf on September 8, 2010.

Dilts DM, Sandler A, Cheng S, et al. Steps and time to process clinical trials at the Cancer Therapy Evaluation Program. J Clin Oncol. 2009;27(11):1761-1766.

Doroshaw JH. Phase '0' Clinical Trials in Cancer Drug Development: From Concept to Practice. Slide presentation, accessed at www.iom.edu/~/media/Files/Activity%20Files/Disease/NCPF/Phase0ClinicalTrialsinCancerDrugDevelopmentFromConcepttoPracticeDoroshow.pdf on September 8, 2010.

ECRI: Should I Enter a Clinical Trial? A Patient Reference Guide for Adults with a Serious or Life-Threatening Illness. ECRI; February 2002. Accessed at www.ecri.org/Documents/Clinical_Trials_Patient_Reference_Guide.pdf on September 8, 2010.

Getz K, Borfitz D. Informed Consent: The Consumer's Guide to the Risks and Benefits of Volunteering for Clinical Trials. Boston, Mass: CenterWatch; 2002.

National Cancer Institute. Learning About Clinical Trials. Accessed at www.nci.nih.gov/clinicaltrials/learning on September 8, 2010.

National Cancer Institute. Monitoring the Safety of Clinical Trials. Accessed at www.cancernet.gov/clinicaltrials/understanding/monitoring-safety-of-trials/allpages on September 8, 2010.

National Cancer Institute. New Approaches to Cancer Drug Development and Clinical Trials: Questions and Answers. Accessed at www.cancer.gov/newscenter/pressreleases/PhaseZeroNExTQandA/print?page=&keyword= on September 8, 2010.

National Institutes of Health Regulations and Ethical Guidelines. The Belmont Report: Ethical Principles and Guidelines for the protection of human subjects of research. Accessed at http://ohsr.od.nih.gov/guidelines/belmont.html on September 8, 2010.

Pharmaceutical Research and Manufacturers of America (PhRMA). 2009 Report: Medicines in Development for Cancer. Accessed at www.phrma.org/files/meds_in_dev/09-046PhRMACancer09_0331.pdf on September 8, 2010.

Streiner DL, Norman GR. Drug Trial Phases. Community Oncology. 2009;6(1):36-40.

US Department of Health and Human Services. Medicare and Clinical Research Studies. March 2010. Accessed at www.medicare.gov/Publications/Pubs/pdf/02226.pdf on September 8, 2010.

US Food and Drug Administration. Access to unapproved drugs. Accessed at www.fda.gov/cder/cancer/access.htm on April 28, 2008. Content no longer available.

US Food and Drug Administration. Investigational New Drug Application. Accessed at www.fda.gov/Drugs/DevelopmentApprovalProcess/HowDrugsareDevelopedandApproved/ApprovalApplications/InvestigationalNewDrugINDApplication/default.htm on September 8, 2010.

US Food and Drug Administration. New Drug Development Timeline. Accessed at www.fda.gov/fdac/graphics/newdrugspecial/drugchart.pdf on April 29, 2008. Content no longer available.